MTMarilda Onghero Taffarel

Marilda Onghero Taffarel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marilda Onghero Taffarel has a total of 100 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Application of physiologically‐based pharmacokinetic modelling to guide oral ketamine prescription in analgesic doses

    by Paulo Roberto Nunes de Goes, Marilda Onghero Taffarel, Andréa Diniz

    Aim: This study aimed to apply physiologically based pharmacokinetic (PBPK) models of ketamine (KET) and its active metabolite norketamine (norKET) after oral administration to evaluate appropriate dosing protocols for racemic KET in ethnically diverse adult populations. Methods: Clinical pharmacokinetic data of S‐ and R‐ketamine and their respective metabolites were obtained from published studies and used to construct PBPK models in Simcyp® Simulator . The models were validated using independent datasets through visual comparison of predicted and observed plasma concentration, time profiles and by calculating mean fold error (MFE) for pharmacokinetic parameters (AUC, Cmax and Tmax). Simulations of multiple oral dosing regimens (0.3–1.25 mg/kg, every 2–12 h) were conducted in virtual Caucasian, Japanese and Chinese populations to determine optimal analgesic ranges. Results: The validated PBPK models accurately predicted plasma exposure for both KET and norKET within acceptable MFE ranges (0.5–2.0). Simulations revealed that in Asian adults, KET exposure was approximately 60% higher and norKET concentrations 25% lower compared with Caucasians. Among the tested regimens, oral doses of 0.75–1.0 mg/kg administered every 6–8 h achieved stable norKET plasma concentrations within the therapeutic range for analgesia, while avoiding levels associated with anaesthetic or adverse effects. Conclusion: The developed PBPK models effectively simulated the pharmacokinetics of oral racemic KET and its metabolite across populations. NorKET appears to be the primary contributor to sustained analgesic activity and represents a suitable marker for plasma monitoring and individualized dose adjustment in clinical practice.

  • Open Access

    Pharmacokinetics of oral-transmucosal ketamine in horses

    by Carlos Rodrigo Komatsu de Alencar, Larissa Lachi-Silva, Paulo Roberto Nunes de Goes, Gustavo Finatti Sakamoto, Andréa Diniz, Marcos Ferrante, Alice Rodrigues de Oliveira, Pedro Henrique Esteves Trindade, José Nicolau Próspero Puoli Filho, Stelio Pacca Loureiro Luna, et al.

    Ketamine is a dissociative anesthetic that has been studied as an adjuvant to control acute and chronic pain in humans. This study defined the pharmacokinetics of ketamine after oral-transmucosal (OTM) administration in horses. Six adult crossbred healthy horses (363 ± 34 kg; 8 ± 3 years) received single OTM ketamine doses of 1.5 and 3.0 mg.kg-1. Blood samples were collected over a period of eight hours. Non-compartmental analysis and population pharmacokinetic modeling were carried out. The absolute bioavailability of ketamine after OTM administration in horses was 31.12 ± 10.98% (1.5 mg.kg-1) and 26.44 ± 11.46% (3.0 mg.kg-1). Plasma concentrations were best described by a two-compartment model, assuming the proportional error model, with an absorption duration of a zero-order kinetic process (tk0), and linear elimination. Population estimates were tk0 of 0.19 h, the apparent clearance (CL/F) was 3,462.97 L.h-1, apparent volume of distribution of the central compartment (V1/F) was 1,820.49 L, apparent volume of distribution of the peripheral compartment (V2/F) was 1,317.22 L, and inter-compartmental clearance (Q/F) was 1,084.98 L.h-1. Between-subject variability in CL/F, V1/F, and Q/F best described the data. The covariates body weight and sex were not significant for incorporation in the final model. The population pharmacokinetic model described the plasma concentrations with reasonable precision and predictive power, OTM administration of ketamine in horses is apparently safe, has a high volume of distribution, bioavailability similar to other species, and the maximum concentration in approximately 15 min.

  • Open Access

    Anesthetic induction with propofol via continuous infusion or bolus in healthy dogs: a randomized clinical trial

    by Gabriela Pereira Souza, Lucas Wamser Fonseca Gonzaga, Pablo Henrique Silva Avelar, Jelieny Aparecida Claudino, Marilda Onghero Taffarel, Marcos Ferrante

    The aim was to compare the administration of propofol via bolus or continuous infusion for anesthetic induction in dogs. Twenty-four healthy adult dogs were randomized into one of two groups: anesthetic induction with intravenous propofol as a 1 mg/kg bolus every 60 seconds (Group B) or continuous infusion at 1 mg/kg/min using a syringe pump (Group CI) following premedication with acepromazine (0.02 mg/kg) and methadone (0.3 mg/kg). The propofol dose, induction time, physiological variables, and the occurrence of myoclonus, hypotension, apnea, desaturation, and hypercapnia after anesthetic induction were evaluated. Independent numerical variables were compared using the Student’s t-test or Mann-Whitney test, while physiological variables were analyzed using repeated measures ANOVA or Friedman test, followed by post hoc comparisons. The significance level was set at P < 0.05. The propofol dose was lower in Group B than in Group CI (3 mg/kg [3 - 3.3] vs. 4.5 mg/kg [3.5 - 5.6], respectively, P = 0.002), and the induction time was shorter in Group B than in Group CI (3 min [3 - 3.25] vs. 4.5 min [3 - 6.25], respectively, P = 0.027) (median and interquartile range). There was no difference in adverse effects between the groups. It is concluded that administering propofol in a 1 mg/kg bolus every 60 seconds allows anesthetic induction with a lower dose and shorter time, with no difference in adverse effects compared to continuous infusion at 1 mg/kg/min.

  • Open Access

    Anais do IV Simpósio do PPS e XIX SEMEVE

    by Flávio Augusto Vicente Seixas, Marilda Onghero Taffarel, Isis Cleópatra Coelho Chaves, Italo Morelli Miacri Souza


  • Open Access

    Dexmedetomidine in Healthy Dogs: Impact on Electrocardiographic Parameters

    by Guilherme Andraus Bispo, Thais Cabral de Oliveira, Marcela Fernanda Moretti, Matheus Fujimura Soares, Lais Calazans Menescal Linhares, Natália Sena Nascimento de Souza, Ana Kelly Sousa da Costa, Marilda Onghero Taffarel, Wagner Luís Ferreira, Paulo Sergio Patto dos Santo

    Objective: To evaluate whether intravenous administration of dexmedetomidine alters the electrocardiographic parameters of healthy dogs. Animals: 22 healthy dogs. Study Design: prospective blind clinical trial. Materials and Methods: The dogs underwent electrocardiographic monitoring at two moments: baseline moment (MB), subjected to tranquilization with butorphanol (0.25 mg/kg/IM), and dexmedetomidine moment (MDEX), after 10 min of intravenous administration of dexmedetomidine (bolus of 2 μg/kg, in 2 minutes, followed by continuous infusion at a rate of 2 μg/kg/hour). Results: After intravenous administration of dexmedetomidine, sinus bradycardia predominated. Regarding electrocardiographic parameters, there was a significant increase in the duration of the P wave (44; 51 ms), QRS complex (62; 67 ms), PR interval (95; 126 ms), and QT interval (207; 252 ms) and reduction in the QTc interval (249; 226 ms), without significant change in systolic, mean, and diastolic blood pressure. Conclusion: Intravenous administration of dexmedetomidine in healthy dogs results in increased parasympathetic tone with significant reduction in heart rate and increased conduction time of electrical impulses in the myocardium.


  • Open Access

    Determinação da taxa de ligação da cetamina às proteínas plasmáticas totais de cães por ultrafiltração e HPLC-ESI-MS/MS

    by Samara Bossa Aleixo, Marilda Onghero Taffarel, Ícaro Putinhon Caruso, Flavio Augusto Vicente Seixas

    A cetamina é um fármaco muito utilizado na Medicina Veterinária para indução e manutenção anestésica, além de promover analgesia. É classificado como um anestésico dissociativo, por exercer seu mecanismo de ação principalmente por bloqueio não competitivo do receptor ionotrópico N-metil D-aspartato (NMDA). A taxa de ligação dos fármacos às proteínas do plasma desempenha um papel importante na disponibilidade de uma droga no organismo, sendo a albumina e alfa-1-glicoproteína ácida as principais proteínas responsáveis por se ligarem aos fármacos. O objetivo desse trabalho foi determinar a taxa de ligação da cetamina às proteínas plasmáticas de cães. As amostras de sangue foram coletadas de quatro cães hígidos e posteriormente centrifugadas para obtenção do plasma. O pH do pool plasmático foi de 7,25 e a concentração de proteínas totais e de albumina, medidos pelo método de Biureto, foram de 51,6 mg/mL e 32,0 mg/mL, respectivamente. A técnica de ultrafiltração associada a cromatografia líquida acoplada a um espectrômetro de massas (HPLC-ESI-MS/MS) foi utilizada neste estudo para avaliar taxa de ligação de cetamina às proteínas plasmáticas totais de cães. Os resultados mostraram que o valor da taxa de ligação da cetamina foi de 84% quando a concentração plasmática do fármaco atingiu 300 ng/mL. A constante de ligação (Kb) foi de 3,76×106 mol/L com um coeficiente de Hill (nH) positivo de 2,8. Os dados encontrados neste trabalho podem contribuir em futuros estudos farmacocinéticos da cetamina em cães.

  • Open Access

    Analysis of the ketamine binding to total plasma protein from domestic cats

    by Victória Paradela Pereira Motta, Fernanda Ferreira da Silva, Ícaro Putinhon Caruso, Paulo Roberto Nunes de Goes, Marilda Onghero Taffarel, Andrea Diniz, Flavio Augusto Vicente Seixas

    A cetamina é um medicamento versátil amplamente utilizado nos ambientes clínico e hospitalar veterinário. A avaliação dos parâmetros de ligação da cetamina às proteínas plasmáticas totais de gatos domésticos fornece informações necessárias na determinação do parâmetro farmacocinético denominado volume de distribuição, o qual é utilizado para a prospecção de concentrações do medicamento em estudos clínicos. O objetivo deste trabalho foi avaliar a taxa de ligação da cetamina às proteínas plasmáticas totais, sua constante (Kb), e modo de ligação à albumina sérica em gatos. Após a aprovação do projeto pelo CEUA/UEM (protocolo 3292020621), uma mistura de plasma de seis animais (n=6) foi reforçada com concentrações de cetamina visando ultrafiltração com membrana de 10 kDa. Os níveis do fármaco antes e depois da ultrafiltração foram analisados pela técnica de Cromatografia Líquida acoplada a Espectrometria de Massas (LC-MS/MS) e os resultados utilizados para calcular a taxa de ligação e a constante de ligação à albumina pelo gráfico de Scatchard. Simulações de docking identificaram os mais prováveis sítios de ligação à proteína. A taxa de ligação da cetamina foi de 65% quando o fármaco atingiu concentrações plasmáticas acima de 300 ng.mL-1, e a constante de ligação foi de 2×106 mol.L–1 com coeficiente de Hill (nH) de 2,3. Estes resultados mostram uma boa correlação entre os parâmetros físico-químicos do fármaco com a avaliação estrutural por meio de docking, além de coerência com os valores relatados por outras metodologias. Este trabalho traz informações sobre o comportamento de ligação da cetamina em proteínas plasmáticas de gatos, parâmetro importante para futuras avaliações farmacocinéticas na busca de melhores protocolos para uso clínico deste medicamento na área veterinária.

  • Open Access

    Hemodynamic Assessment via Echocardiography During Propofol Anesthetic Induction in Healthy Dogs

    by Thais Cabral de Oliveira, Guilherme Andraus Bispo, Laura Beatriz de Socorro Poleto, Francisco Dantas de Maio Martinez, Max Túlio Rocha de Souza, Lais Calazans Menescal Linhares, Marilda Onghero Taffarel, Wagner Luís Ferreira, e Paulo Sérgio Patto dos Santos

    Introduction: Propofol is an intravenous anesthetic administered as a bolus or continuous infusion during anesthetic induction and maintenance. Its pharmacokinetic characteristics include hepatic and extrahepatic metabolism with a rapid onset of action and short duration, which provides a smooth anesthetic induction without excitatory effects.Objective: To evaluate whether the isolated use of propofol in anesthetic induction in dogs changes the hemodynamic variables assessed via echocardiography.Study Design: Prospective clinical study.Animals: Twelve healthy dogs.Methods: The dogs were induced with propofol (dose/effect) at 3 mg/kg/minute, and echocardiographic evaluations were performed immediately before anesthetic induction (MB) and immediately after its interruption (MI), at the end of the supply of the anesthetic agent.Results: A significant reduction was observed between the values of the following hemodynamic variables: Ejection Fraction (EF%), which varied from 70% to 65% (p = 0.011) between moments, and the Doppler Ejection Index (DEI), which ranged from 27.1 mL/beat/m2 to 22.4 mL/beat/m2 (p = 0.044). The heart rate (HR) and the other studied hemodynamic variables showed no significant differences between the evaluated moments.Conclusion and Clinical Relevance: Propofol was a safe anesthetic‐inducing agent, maintaining stable hemodynamic indices during anesthetic induction at the used rate.


  • Avaliação da pressão dos manguitos dos tubos endotraqueais em cães e gatos

    by Felipe Gava, Universidade Estadual de Maringá, Marilda Onghero Taffarel

  • Métodos utilizados para avaliação da eficácia analgésica de opioides e anti-inflamatórios não-esteroidais em gatos

    by Universidade Estadual de Maringá, Gabriela Godoi Marques, Marilda Onghero Taffarel

    Ineffective pain treatment causes complicated situations, such as poor recovery and chronic pain in the patient. The recognition of feline pain is a great challenge, requiring training and scoring systems to assess pain in cats. Pain classification methods were created with the aim of helping professionals. The aim of this review was to verify which pain assessment and antinociception methods were used to assess the analgesic efficacy of opioids and non-steroidal anti-inflammatory drugs in cats with acute pain. The most used pain assessment method was thermal stimulation. Most studies found showed the analgesic efficacy of drugs.